BR0207817A - Processo para preparar um composto, e, composto - Google Patents

Processo para preparar um composto, e, composto

Info

Publication number
BR0207817A
BR0207817A BR0207817-1A BR0207817A BR0207817A BR 0207817 A BR0207817 A BR 0207817A BR 0207817 A BR0207817 A BR 0207817A BR 0207817 A BR0207817 A BR 0207817A
Authority
BR
Brazil
Prior art keywords
compound
synthesis
chiral
asymmetric
preparing
Prior art date
Application number
BR0207817-1A
Other languages
English (en)
Portuguese (pt)
Inventor
William Brown
Niklas Plobeck
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of BR0207817A publication Critical patent/BR0207817A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Quinoline Compounds (AREA)
  • Furan Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
BR0207817-1A 2001-03-07 2002-03-05 Processo para preparar um composto, e, composto BR0207817A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0100764A SE0100764D0 (sv) 2001-03-07 2001-03-07 New assymetric process
PCT/SE2002/000376 WO2002070492A1 (en) 2001-03-07 2002-03-05 New asymmetric process for the preparation of diarylmethylpiperazines derivatives and novel asymmetric diarylmetylamines as intermediates

Publications (1)

Publication Number Publication Date
BR0207817A true BR0207817A (pt) 2004-03-09

Family

ID=20283236

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0207817-1A BR0207817A (pt) 2001-03-07 2002-03-05 Processo para preparar um composto, e, composto

Country Status (20)

Country Link
US (2) US7045625B2 (enExample)
EP (1) EP1368325B1 (enExample)
JP (1) JP2004522793A (enExample)
KR (1) KR100856996B1 (enExample)
CN (2) CN1244565C (enExample)
AT (1) ATE406354T1 (enExample)
BR (1) BR0207817A (enExample)
CA (1) CA2440104A1 (enExample)
DE (1) DE60228548D1 (enExample)
DK (1) DK1368325T3 (enExample)
ES (1) ES2311050T3 (enExample)
IL (1) IL157460A0 (enExample)
MX (1) MXPA03007889A (enExample)
NO (1) NO325156B1 (enExample)
NZ (1) NZ527656A (enExample)
PT (1) PT1368325E (enExample)
SE (1) SE0100764D0 (enExample)
SI (1) SI1368325T1 (enExample)
WO (1) WO2002070492A1 (enExample)
ZA (1) ZA200306448B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114560781A (zh) * 2022-03-01 2022-05-31 无锡捷化医药科技有限公司 一种n,n-二(2-氯乙基)-4-硝基苯基丙氨酸甲酯的制备方法
CN114702457A (zh) * 2022-03-30 2022-07-05 青岛科技大学 一种二芳基甲胺类化合物的绿色合成方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9202238D0 (en) * 1992-02-03 1992-03-18 Wellcome Found Compounds
HU221726B1 (hu) * 1993-07-30 2002-12-28 Ardent Pharmaceuticals Inc. Piperazinszármazékok, e vegyületeket tartalmazó gyógyászati készítmények és eljárás a vegyületek előállítására
SE9504661D0 (sv) * 1995-12-22 1995-12-22 Astra Pharma Inc New compounds
SE9904673D0 (sv) * 1999-12-20 1999-12-20 Astra Pharma Inc Novel compounds
SE0001209D0 (sv) * 2000-04-04 2000-04-04 Astrazeneca Canada Inc Novel compounds

Also Published As

Publication number Publication date
CN1244565C (zh) 2006-03-08
MXPA03007889A (es) 2003-12-04
KR20030080075A (ko) 2003-10-10
US20060074238A1 (en) 2006-04-06
CA2440104A1 (en) 2002-09-12
ZA200306448B (en) 2004-09-08
JP2004522793A (ja) 2004-07-29
KR100856996B1 (ko) 2008-09-04
CN1494532A (zh) 2004-05-05
SI1368325T1 (sl) 2008-12-31
NO20033944D0 (no) 2003-09-05
DE60228548D1 (de) 2008-10-09
HK1059436A1 (en) 2004-07-02
NZ527656A (en) 2005-04-29
IL157460A0 (en) 2004-03-28
CN1721407A (zh) 2006-01-18
US7045625B2 (en) 2006-05-16
PT1368325E (pt) 2008-10-27
EP1368325B1 (en) 2008-08-27
NO20033944L (no) 2003-10-31
NO325156B1 (no) 2008-02-11
ES2311050T3 (es) 2009-02-01
SE0100764D0 (sv) 2001-03-07
EP1368325A1 (en) 2003-12-10
US20040077861A1 (en) 2004-04-22
CN1295217C (zh) 2007-01-17
US7423154B2 (en) 2008-09-09
WO2002070492A1 (en) 2002-09-12
ATE406354T1 (de) 2008-09-15
DK1368325T3 (da) 2008-11-24

Similar Documents

Publication Publication Date Title
BRPI0411268A (pt) processo para a preparação de um composto 3-aril butil-amina substituìdo
CR10177A (es) Resolución de sal quiral. (divisional)
BR0313070A (pt) Métodos para preparação de um diastereÈmero desejado de uma tetraidro-beta-carbolina e para preparação de um composto
BRPI0407282A (pt) Processo para preparação de inibidores de pirrolotriazina cinase
EA200600485A1 (ru) Способ получения производных 2-оксо-1-пирролидина
BR0111472A (pt) Processo para a preparação de um composto, composto, e, forma polimórfica de um composto
DE60228724D1 (de) Verfahren zur herstellung von beraprost und dessen salzen
EA200701738A1 (ru) Способ получения транс-1-((1r,3s)-6-хлор-3-фенилиндан-1-ил)-3,3-диметилпиперазина
AR072336A1 (es) Derivados de la 3-carboxipropil-aminotetralina, composiciones farmaceuticas que los contienen, procedimiento para su preparacion, intermediarios y su procedimiento de preparacion
BR0207817A (pt) Processo para preparar um composto, e, composto
BRPI0500590B8 (pt) processo para a síntese de compostos de 1,3,4,5-tetraidro-2h-3-benzazepin-2-ona, e aplicação na síntese de ivabradina e sais de adição desta com um ácido farmaceuticamente aceitável
BR0113259A (pt) Processo para a preparação de um composto, composto e processo para a preparação de compostos
BRPI0408680A (pt) processo para produzir álcoois e aminas enantiomericamente enriquecidos
DE602004008486D1 (de) Verfahren zur herstellung von (1s,4r)-cis-4-ä2-amino-6-chlor-9h-purin-9-ylü-2-cyclopenten-1-methanol
DE60106778D1 (de) Verfahren zur herstellung von vitronectin-rezeptorantagonisten
DE602004006021D1 (de) Verfahren zur racematspaltung von nefopam
AR044670A1 (es) Procedimiento para la sintesis del acido (2s, 3as, 7as) - perhidroindol - 2 carboxilico y aplicacion en la sintesis de perindopril
ECSP034515A (es) Proceso para producir compuestos quirales
BR0116853A (pt) Processo para a preparação de um composto, e, composto.
ATE346837T1 (de) Verfahren zur herstellung des inneren salzes von (r)- or (s)-aminocarnitin, salze und derivate davon
UA91153C2 (ru) Способ получения формы и венлафаксина гидрохлорида
AR046627A1 (es) Procesos para la preparacion de ftalimidas n- sustituidas
BR0311761A (pt) Processo para a preparação de 4,6-dicloro-5-fluorpirimidina
AR062481A1 (es) Proceso para preparar derivados de indolinona fenilaminopropanol
ATE502045T1 (de) Verfahren zur herstellung von perindoprilerbumin

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 9A ANUIDADE(S).

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2103 DE 26/04/2011.